No Data
No Data
ViiV Reports Positive Real-world Data for HIV Prevention Drug
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans
Takeda Declines to Exercise Option for Wave's WVE-003
Wave Stock Soars 38% on Positive Data for AATD Therapy WVE-006
Express News | ViiV Healthcare, Owned By GSK, Pfizer And Shionogi, Announced The Presentation Of New Real-world Evidence And Implementation Data Showing The Effectiveness, Adherence, And Quality-of-life Improvement Of Apretude (Cabotegravir Long-acting) For HIV...
No Data
No Data